Izindaba zakamuva ngomdlavuza
I-Amivantamab-vmjw igunyazwe yi-USFDA yezinkomba zomdlavuza wamaphaphu we-EGFR exon 20 oguquliwe ongewona omncane weseli
I-Food and Drug Administration igunyaze i-amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.) ngokuhlanganiswa ne-carboplatin futhi yafakwa nge-pemetrex ngomhla ka-1 Mashi 2024....
I-Osimertinib ene-chemotherapy igunyazwe yi-USFDA ye-EGFR-mutated non-small cell lung cancer.
I-Food and Drug Administration igunyaze i-osimertinib (i-Tagrisso, i-AstraZeneca Pharmaceuticals LP) ihlanganiswe ne-chemotherapy esekelwe ku-platinum yeziguli...
I-Lifileucel igunyazwe yi-USFDA ngemelanoma engasabukeki noma ye-metastatic
I-Food and Drug Administration inikeze ukugunyazwa okusheshisiwe kwa-lifileucel (Amtagvi, Iovance Biotherapeutics, Inc.) ngomhla ka-Februwari 16, 2024. Le mvume inge...
I-Tepotinib igunyazwe yi-USFDA ngomdlavuza wamaphaphu we-metastatic ongewona omncane
I-Food and Drug Administration igunyaze ngokusemthethweni i-tepotinib (Tepmetko, EMD Serono, Inc.) ngoFebhuwari 15, 2024, ezigulini ezikhulile ezine-metastatic engeyona encane...
I-Irinotecan liposome igunyazwe yi-USFDA yokwelashwa komugqa wokuqala we-metastatic pancreatic adenocarcinoma
I-Food and Drug Administration igunyaze i-irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals, Inc.) ene-oxaliplatin, i-fluorouracil, ne-leucovorin ku-...
I-Erdafitinib igunyazwe yi-USFDA nge-carcinoma ye-urothelial ethuthukisiwe endaweni noma ye-metastatic
I-Erdafitinib (i-Balversa, i-Janssen Biotech) yagunyazwa yi-Food and Drug Administration ngoJanuwari 19, 2024, ezigulini zabantu abadala ezinezinguquko zofuzo ze-FGFR3...
I-Pembrolizumab ene-chemoradiotherapy igunyazwe yi-USFDA ye-FIGO 2014 Stage III-IVA umdlavuza womlomo wesibeletho
I-Food and Drug Administration igunyaze i-pembrolizumab (Keytruda, Merck) ihlanganiswe ne-chemoradiotherapy (CRT) yeziguli ezine-FIGO 2014 Stage...
I-Enfortumab vedotin-ejfv ene-pembrolizumab igunyazwe yi-USFDA ngomdlavuza we-urothelial othuthukile endaweni noma we-metastatic
Kusukela ngomhla ka-15 Disemba 2023, i-Food and Drug Administration (FDA) igunyaze i-enfortumab vedotin-ejfv (Padcev, Astellas Pharma) kanye ne-pembrolizumab (Keytruda,...
I-Belzutifan igunyazwe yi-USFDA ye-Advanced renal cell carcinoma
I-Food and Drug Administration inikeze imvume ye-belzutifan (Welireg, Merck & Co., Inc.) ngomhla ka-14 Disemba 2023, ezigulini ezinamaseli ezinso ezithuthukisiwe...
I-Eflornithine ivunywe yi-USFDA kuziguli ezikhulile nezezingane ezine-neuroblastoma eyingozi kakhulu
I-FDA igunyaze i-eflornithine (IWILFIN, USWM, LLC) ngomhla ka-13 Disemba 2023, ukuze yehlise ingcuphe yokuphinda yenzeke kubantu abadala nasezinganeni ezine-neuroblastoma engcuphe kakhulu...
I-Pirtobrutinib igunyazwe yi-USFDA ye-lymphocytic leukemia engapheli kanye ne-lymphocytic lymphoma encane
I-Food and Drug Administration inikeze ukugunyazwa okusheshisiwe kwe-pirtobrutinib (Jaypirca, Eli Lilly and Company) ngomhla ka-1 Disemba 2023, kubantu abadala abanezifo ezingelapheki...
I-Nirogacestat igunyazwe yi-USFDA ngamathumba e-desmoid
I-Food and Drug Administration igunyaze i-nirogacestat (OGSIVEO, SpringWorks Therapeutics, Inc.) ngoNovemba 27, 2023, ezigulini ezikhulile ezithuthukayo...
Dinga usizo? Ithimba lethu likulungele ukukusiza.
Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.